Perrigo has filed for regulatory approval of a generic version of an over-the-counter medication for...
Drug maker Warner Chilcott will buy the U.S. rights to a treatment for overactive bladder...
A U.S. District Court has blocked Canadian generic drug maker Apotex from selling generic versions...
Merck is expanding its patient assistance program, the drug maker said Wednesday....
Starting Monday, K-V Pharmaceutical will ship its first product since it withdrew several products in...
The federal government got a kick in the face Thursday as an appeals court ruled...
Efforts by two generic drug makers to market a generic version of a drug for...
This week’s decision by the U.S. Second Circuit Court of Appeals could make political efforts...
Hi-Tech Pharmacal had $40.4 million in sales during its fiscal first quarter ended July 31,...
The generics division of Pfizer will sell an authorized generic version of a drug used...
Swiss drug maker Lonza will help British drug maker GlaxoSmithKline manufacture five biotech drugs in...
The Food and Drug Administration has approved a generic oral contraceptive made by Watson Pharmaceuticals,...
The generics subsidiary of Pfizer is launching a new business focused on authorized generics....
GlaxoSmithKline Consumer Healthcare on Tuesday named Stacy Wallace to the newly created role of VP...
Generic drug maker Watson Pharmaceuticals has applied for Food and Drug Administration approval for a...
Pfizer is pulling out of a development deal for a potential brain cancer drug, saying...
Teva Pharmaceuticals has launched a generic treatment for epileptic seizures....
Eli Lilly's method-of-use patents for its osteoporosis drug were declared valid by a federal court...
The Food and Drug Administration has pushed back its review date for a drug made...
After Sanofi-Aventis sent Genzyme a second proposal letter to acquire the drug maker on Monday,...
The U.S. drug market will present opportunities as well as uncertainties over the next decade,...
A generic drug maker has filed an abbreviated new drug application for its version of...
Jeffrey Bailey has been appointed as King Pharmaceuticals' chief commercial officer, leading all sales, marketing,...
Sanofi-Aventis is looking to acquire Genzyme with a nonbinding proposal valued at approximately $18.5 billion....
A drug maker and a consumer packaged goods company will co-promote a newly approved insomnia...